Publication Name	World Journal of Clinical Cases
Manuscript ID	6806
Country	Switzerland

Received	2013-10-29 11:03
Peer-Review Started	2013-10-29 20:56
To Make the First Decision	2013-11-19 12:56
Return for Revision	2013-11-19 15:59
Revised	2013-11-29 17:26
Second Decision	2013-12-19 13:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-12-19 13:27
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-12-30 19:23
Typeset the Manuscript	2014-01-09 18:01
Publish the Manuscript Online	2014-01-16 15:24

ISSN	2307-8960 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Case Report
Article Title	Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case
Manuscript Source	Invited Manuscript
All Author List	Gian Marco Rosa, Antonello Parodi, Ulrico Dorighi, Federico Carbone, François Mach, Alessandra Quercioli, Fabrizio Montecucco, Nicolas Vuilleumier, Manrico Balbi and Claudio Brunelli
Funding Agency and Grant Number	Funding Agency Grant Number Swiss National Science Foundation 310030_118245 Swiss National Science Foundation 32003B_134963/1
Corresponding Author	Fabrizio Montecucco, MD, PhD, Division of Cardiology, Department of Internal Medicine, Foundation for Medical Researches, University of Geneva, 6 viale Benedetto XV, 1211 Geneva, Switzerland. fabrizio.montecucco@unige.ch
Key Words	Mitral valve; Thrombus; Prosthetic valve; Atrium; Hepatotoxicity
Core Tip	Thromboembolism represents an important complication following heart valve replacement. This case report shows that although vitamin K antagonist (VKA) treatment represents the elective therapy in patients with left atrial thrombosis without mitral valve dysfunction, it may not be sufficient to avoid thrombogenesis. We also recommend that the discontinuation of VKA during the first three months after mitral valve surgery has to be carefully considered, especially in high thromboembolic risk patients.
Publish Date	2014-01-16 15:24
Citation	Rosa GM, Parodi A, Dorighi U, Carbone F, Mach F, Quercioli A, Montecucco F, Vuilleumier N, Balbi M, Brunelli C. Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. World J Clin Cases 2014; 2(1): 20-23
URL	http://www.wjgnet.com/2307-8960/full/v2/i1/20.htm
DOI	http://dx.doi.org/10.12998/wjcc.v2.i1.20

Full Article (PDF)	wjcc-2-20.pdf
Full Article (Word)	wjcc-2-20.doc
Manuscript File	6806-Review.doc
Answering Reviewers	6806-Answering reviewers.pdf
Copyright License Agreement	6806-Copyright assignment.pdf
Peer-review Report	6806-Peer review(s).pdf
Scientific Editor Work List	6806-Scientific editor work list.doc